Preparation and characterization of protein C-loaded PLA nanoparticles.
暂无分享,去创建一个
C Vigneron | R. Gref | E. Dellacherie | R Gref | E Dellacherie | M F Zambaux | F Bonneaux | M. Zambaux | F. Bonneaux | C. Vigneron
[1] A. Chang,et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. , 1987, The Journal of clinical investigation.
[2] Robert K. Scopes,et al. Protein Purification: Principles and Practice , 1982 .
[3] T. Park,et al. Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles , 1996 .
[4] C Vigneron,et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[5] R. Bodmeier,et al. The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems , 1989 .
[6] G. Peterson,et al. A simplification of the protein assay method of Lowry et al. which is more generally applicable. , 1977, Analytical biochemistry.
[7] B. Gander,et al. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.
[8] Hatem Fessi,et al. In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities , 1996 .
[9] J. Féger,et al. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. , 1996, Journal of biomedical materials research.
[10] María J. Alonso,et al. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .
[11] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[12] P. Couvreur,et al. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. , 1993, Journal of biomedical materials research.
[13] R. Marlar,et al. Contribution of Plasma Proteinase Inhibitors to the Regulation of Activated Protein C in Plasma , 1993, Thrombosis and Haemostasis.
[14] Michel Veillard,et al. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers , 1995 .
[15] Robert J. Levy,et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery , 1997 .
[16] Tae Gwan Park,et al. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .